Related Experiment Video

Updated: Nov 10, 2025

Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

34.3K

Metformin: A Potential Candidate for Targeting Aging Mechanisms

Die Hu1,2, Fangfang Xie1,2, Yongwei Xiao1,2

  • 11The First School of Clinical Medicine, Gannan Medical University, Ganzhou, China.

Aging and Disease
|April 5, 2021
PubMed

Insights

Metformin, a common diabetes drug, shows potential for anti-aging effects by influencing aging pathways. Further research into its molecular mechanisms could reveal new ways to delay aging and maintain health in older populations.

Area of Science:

  • Gerontology
  • Pharmacology
  • Molecular Biology

Background:

  • Aging is a natural process characterized by declining fitness and increased disease risk.
  • The growing aging population presents significant societal and health challenges.
  • Novel anti-aging interventions are crucial for maintaining healthspan.

Purpose of the Study:

  • To review the molecular mechanisms of aging.
  • To explore the anti-aging effects of metformin.
  • To understand metformin's potential in modulating aging pathways.

Main Methods:

  • Literature review of aging mechanisms.
  • Analysis of studies on metformin's effects on aging-related pathways.
  • Synthesis of current research on metformin and aging.

Main Results:

  • Metformin, a hypoglycemic drug, is investigated for its anti-aging properties.
  • Evidence suggests metformin influences key aging-related molecular pathways.
  • These modulations may contribute to delaying the aging process.

Conclusions:

  • Metformin exhibits potential as an anti-aging agent.
  • Understanding its molecular targets is key to its therapeutic application.
  • Further research can elucidate metformin's role in promoting healthy aging.
Keywords:
Insulin-Like Growth Factor Iagingmetforminoxidative stressproteostasis

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.9K
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.5K

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
420
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
68
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
70
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
17.3K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
405
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
70